• Fang-Ping Xiao, Ming-Yue Chen, Lei Wang, Hao He, Zhi-Qiang Jia, Lin Kuai, Hai-Bo Zhou, Meng Liu, and Mei Hong.
• Department of Cardiology, Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
• Am J Emerg Med. 2021 Apr 1; 42: 23-30.

BackgroundThe outcomes of new-onset atrial fibrillation (AF) during sepsis are inconsistent and inconclusive. This meta-analysis aims to provide a comprehensive description of the impact of new-onset AF on the prognosis of sepsis.MethodsThree electronic databases (PubMed, Embase, and the Cochrane Library) were searched for relevant studies. Meta-analysis was performed using odds ratios (OR) and 95% confidence intervals (CI) as effect measures.ResultsA total of 225,841 patients from 13 individual studies were incorporated to the meta-analysis. The summary results revealed that new-onset AF during sepsis was associated with increased odds of in-hospital mortality (pooled OR: 2.09; 95% CI: 1.53-2.86; p < 001), post-discharge mortality (pooled OR: 2.44; 95% CI: 1.81-3.29; p < .001), and stroke (pooled OR:1.88; 95% CI: 1.13-3.14; p < .05). Results also indicated that the incidence of new-onset AF varied from 1.9% for mild sepsis to 46.0% for septic shock. Furthermore, compared to those without AF, people with new-onset AF had longer ICU and hospital stays, as well as a higher recurrence of AF.ConclusionsNew-onset AF is frequently associated with adverse outcomes in patients with sepsis. This is a clinical issue that warrants more attention and should be managed appropriately to prevent poor prognosis.Copyright © 2020. Published by Elsevier Inc.

23 keywords...

hide…